Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients?

Publisher： Karger

E-ISSN： 1423-0232|78|3-4|189-195

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.3-4, 2010-04, pp. : 189-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Haffty B.G.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-641

Elsevier

Access to resources Recommend Favorite

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Vaidya J.S.   Baum M.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-640

Elsevier

Access to resources Recommend Favorite

Frequent Loss of the BLID Gene in Early-Onset Breast Cancer

By  

Cytogenetic and Genome Research, Vol. 135, Iss. 1, 2011-08 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

Subsequent skin cancer in patients with early‐onset basal cell carcinoma

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 3, 2015-08 ,pp. : 236-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

There Is a Significant Association between 100% Treatment Adherence and Higher Recurrence-Free and Overall Survival in Early-Onset Patients with Breast Cancer – Conclusions from an Empty Subset of Patients Do Not Change This Statement

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 303-305

Karger

Access to resources Recommend Favorite